The global cancer burden continues to rise at an alarming rate.
The global cancer burden continues to rise at an alarming rate. 1 It is estimated that there were 15.2 million new cancer cases and 8.8 cancer-related deaths in 2015.
1 It is predicted that by the year 2035, there will be 23.9 million new cancer cases and 14.6 million cancer-related deaths. 1 Cancer is currently the second-leading cause of death worldwide, second only to cardiovascular disease. 2 Globally, deaths related to cancer increased by 45% between 1990 and 2013. 3 In a recent update, the Global Burden of Disease study group noted that cancer-related mortality increased by 17% between 2006 and 2016. 4 It is likely that at this rate cancer can become the leading cause of death in the near future.
Surgery plays a vital role in the treatment paradigm for cancer patients. The Lancet oncology commission on global cancer surgery predicted that more than 80% of people diagnosed with cancer will need a surgical procedure. 5 It is estimated that by 2030, 45 million additional surgical procedures will be needed to treat patients diagnosed with cancer. 5 Despite this rising need, only 25% of the patients worldwide will receive safe, timely, affordable, and highquality surgical care. 5 The majority of cancer patients in the low-to middle-income countries will be the most affected due to these disparities in surgical care for cancer patients. 5 The inability to access timely and safe surgical care for cancer patients can lead to a cumulative gross domestic product loss of US $6.2 trillion by 2030.
Multiple factors contribute to the inadequacy and inequity in surgical care for cancer patients globally. Several entities, such as the Lancet Oncology Commission and the World Health Organization, are actively working towards reducing the cancer burden and to improve surgical care for cancer patients. 5, 6 The Global Forum of Cancer Surgeons (GFCS) was formed in 2017 under the auspices of the Society of Surgical Oncology and several other surgical oncology societies across the world. 7 The GFCS has a similar purpose of addressing disparities and improving surgical care for cancer patients worldwide. 7, 8 ''The mission of the GFCS is to provide a voice for cancer surgeons to improve surgical care for cancer patients through clinical care, education, research, outreach, advocacy, and leadership on the global stage.'' 8 The cancer burden from the countries currently represented in the GFCS accounts for the majority of the global cancer burden (77.5% of the new cancer cases and 75.7% of cancerrelated mortality). 8 At its inaugural meeting in 2017, the members of the GFCS proposed an initial brief qualitative pilot survey (Supplemental Fig. 1 ) to explore the barriers to surgical care for cancer patients and identify potential solutions. The survey was distributed to the surgical oncology leaders from all eight countries outside of the United States, Canada, and Europe. These countries included: Brazil, China, Egypt, India, Israel, Japan, Mexico, and South Korea. We received responses from all eight countries representing diverse regions of the world with a response rate of 100%. The perceived barriers to providing optimal surgical care for cancer patients for all domains in their respective countries are outlined in Tables 1, 2, 3 and 4.
The perceived barriers to providing adequate surgical care for cancer patients in the arena of education are highlighted in Table 1 . One of the major barriers appears to be the lack of standardized training for surgical oncologists. The lack of standardization in content and length of training for surgical oncology can be alleviated by utilizing the curriculum jointly developed by the Society of Surgical Oncology and the European Society of Surgical Oncology. 9, 10 This modular curriculum with modifications tailored to individual countries can serve as a foundational scaffolding to standardize surgical oncology training and thereby build a sustainable surgical oncology workforce.
The perceived barriers relating to the domain of clinical care are highlighted in Table 2 . The major barriers appear to be related to the lack of resources and is similar across most of the countries. This lack of resources results in downstream multiplication of inadequacies in many avenues ranging from: lack of specialized cancer centers, insufficient number of specialized professionals, inadequate resources to perform optimal staging, inability to develop or follow evidence-based guidelines and the issues related to urban versus rural disparities.
The perceived barriers in the arena of research are highlighted in Table 3 . The lack of a research curriculum to teach and acquaint surgical oncology trainees and practicing physicians with the fundamental basics of research was noted as a major barrier. The global curriculum in research literacy jointly developed by the The inability to publish or present their research projects was noted to discourage researchers. The Global Poster session at the annual cancer symposium of the Society of Surgical Oncology provides a forum for young surgical oncologists to display their research projects. 13 The Chinese Society of Clinical Oncology provides a similar opportunity for researchers to present their projects at their annual meeting.
14,15
The perceived barriers to providing safe, timely and optimal surgical care to cancer patients in the arena of workforce are highlighted in Table 4 . Barring Israel, all the other countries under discussion in this context rank within the top 30 most populous countries in the world with 6 countries (South Korea is currently ranked at 27) within the top 14. Not surprisingly, all the countries reported large volumes of patient population and inadequate number of qualified health care personnel being the cause of suboptimal surgical cancer care delivery. Inadequate pay for the amount of work along with long work hours, large volume load, and poor working environment were the other reported factors.
The surgical oncology leaders from various countries were asked to outline some broad solutions to the identified barriers (Table 5 ). Although each country had their own areas of emphasis, we noted several overlapping solutions. In countries, such as Brazil, China, Japan, and Mexico, leaders felt that a multidisciplinary approach based on clinical guidelines needed to be promoted. Many countries highlighted the benefits of international observerships and educational opportunities that permit the bidirectional transfer of best educational, clinical, and research practices. The Society of Surgical Oncology, European Society of Surgical Oncology, Brazilian Society of Surgical Oncology, Japanese Society of Gastrointestinal Surgery, Korean Society of Surgical Oncology, and several other organizations already provide such overseas observership opportunities that can be of significant value for bidirectional transfer of knowledge and best practices.
16-18 The International Career Development Exchange (ICDE) provides funding and infrastructure for candidates from other countries to attend the annual cancer symposium of the Society of Surgical Oncology and also visit premier Surgical Oncology Institutions in the United States. 16 The European Society of Surgical Oncology offers trainees in surgical oncology the opportunity to visit a specialist centre outside of their native country. 17 Similarly, the Brazilian Society of Surgical Oncology provides funding and administrative support for young surgical oncologists to attend their annual meeting.
18 Several other societies, such as the Indian Association of Surgical Oncology, are in the process of developing new observerships. These multiple observerships not only provide some amount of funding to defray the costs but also serve as major platforms for collaborations to improve surgical care for cancer patients globally.
The survey was distributed to the elected leaders of the various surgical oncology societies of the world. The results are the perceptions of the leaders and may not be reflective of the perceptions of their entire respective countries and do not include the perceptions of the members of these societies. In addition, it takes into account the opinions of several other surgical disciplines that perform cancer surgery. The survey was distributed to eight member countries of the GFCS, which account for a large population of the world. Several other countries not within the GFCS but with a rising cancer burden and surgical inequities in cancer care were not included in the survey. Finally, this project was designed as a pilot qualitative study. As a result, the paper does not propose to identify solutions to all barriers or provide a quantifiable estimate of the burden for those barriers. It is hoped that in the future a more comprehensive survey can be distributed not to only the leaders but also to the broader membership of the partner societies. It would be beneficial to obtain the opinions of not only fellowship-trained surgical oncologists but also general surgeons and surgeons from various training pathways who still perform a major share of cancer surgery across the world. Finally, we hope the comprehensive survey can capture data from all parts of the world with diverse representation from various countries not included in the current study. In summary, the Global Forum of Cancer Surgeons appears to be a stable body of cancer surgeons from across the world that can work well together and speak as one cohesive voice to address inequities in surgical care for cancer patients globally. The success of the initial qualitative pilot survey demonstrates that the Global Forum of Cancer Surgeons has the potential to play a larger role on the global stage of cancer surgery. The initial qualitative pilot survey identified barriers to surgical care with multiple common themes for the various surveyed countries. This commonality can help to build synergistic solutions that can be cost-effective when modified and implemented on the global stage. Several of the barriers will need new solutions but for some, many solutions offered by the various surgical oncology societies across the world and within the GFCS are already in existence. The Global Forum of Cancer Surgeons has been instrumental in bringing these multiple surgical oncology societies together to reap the benefits of the collaborative work between the societies. It is hoped that the Global Forum of Cancer Surgeons will continue to grow and remain a viable body to promote safe, timely, accessible and high-quality surgical care for cancer patients globally. 
